COMP <GO>
GEHC vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
GE HealthCare Technologies Inc. Common Stock (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: GEHC 8
— UNH 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: GEHC
LAST: $76.57 (+0.20%) • MKT CAP: $34.55B
roic
14.20%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEHC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEHC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.00% | 88.57% | -48.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 14.20% | 11.47% | +2.73 | GEHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.1x | 16.4x | -5.35 | GEHC | /valuation <GO> |
| Free Cash Flow Yield | 4.19% | 6.48% | -2.29 | UNH | /fcf-yield <GO> |
| Operating Margin | 13.40% | 4.82% | +8.58 | GEHC | /operating-margins <GO> |
| Net Profit Margin | 10.10% | 3.14% | +6.96 | GEHC | /net-margins <GO> |
| Revenue Growth (YoY) | 4.80% | 6.46% | -1.66 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 2.28% | -2.09 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.90 | 3.12 | -1.22 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | GEHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.74% | +0.66 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.1 | 56.0 | +18.05 | GEHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.33 | +0.82 | GEHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.4x | 17.1x | -1.69 | GEHC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $34.55B | $364.66B | -$330.11B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEHC REV | UNH REV | GEHC GROSS % | UNH GROSS % | GEHC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.63B | $447.57B | 40.0% | 88.7% | $1.41B | $16.07B |
| FY 2024 | $19.67B | $400.28B | 41.7% | 88.3% | $1.35B | $20.70B |
| FY 2023 | $19.55B | $371.62B | 44.0% | 89.6% | $876.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEHC // BETA 1.15
UNH // BETA 0.33